B. Riley Financial
DMK

B. Riley Financial’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

B. Riley Financial’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-3,318
Closed -$1.02M – 339
2017
Q4 		$1.02M Buy
+3,318
New +$1.09M 0.27% 93

Other funds holding DMK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bard Associates
Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return
Leisure Capital Management
Leisure Capital Management Costa Mesa, California $320M AUM 39.11% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Walleye Trading
Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

B. Riley Financial's DMK Position: Q1 2018 in Review

B. Riley Financial sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2018, closing a stake of 3,318 shares — an estimated $1.02M sold.

B. Riley Financial first reported a position in DMK in Q4 2017 and held it in 1 quarter. The position peaked at $1.02M in Q4 2017. 52 funds tracked by Wall St. Rank hold DMK as of Q1 2018.

  • B. Riley Financial reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2018 after selling out during the quarter.
  • B. Riley Financial sold 3,318 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2018, an estimated $1.02M.
  • B. Riley Financial first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q4 2017 and held it in 1 quarter.
  • B. Riley Financial's DMK Pharmaceuticals Corporation Common Stock position peaked at $1.02M in Q4 2017.
  • 52 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2018.

Based on B. Riley Financial's 13F filing for Q1 2018, filed 4 May 2018.